Skip to main content
Log in

Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was evaluation of the efficacy of the first step of a two-stage procedure for treatment of hip prosthetic joint infection (PJI) using articulating and non-articulating spacers as well as development of a prediction model and prognostic score for infection recurrence.

Methods

In a cohort of 217 patients treated for PJI of the hip, demographic characteristics, clinical symptoms, body temperature, body mass index (BMI), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell count (WBC), microbiological cultures and the type of the spacer used were retrospectively analyzed for association with the recurrence of PJI.

Results

Patients with infection recurrence had increased levels of ESR and CRP (P < 0.001) together with higher BMI and shorter infection manifestation period after previous surgery (P < 0.05). Among these patients, there was no significant difference of clinical characteristics between subjects with articulating and non-articulating spacers. Microbial associations were more often identified in patients with recurrent infection (50 %, P < 0.01) where Gram-negative bacteria were predominant (61.5 %, P < 0.01). These patients had higher percentage of Acinetobacter sp. and P. aeruginosa isolates (28.2 %, P < 0.01).

Conclusions

Efficacy of the first step of two-stage revision was 64.1 %. Placement of either articulating or non-articulating spacers did not influence recovery from PJI. Laboratory values of ESR, CRP, BMI and the type of previous surgery were identified as main factors that affect outcomes of the two-stage procedure. A prognostic model with the calculation of a total risk score for PJI recurrence was developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lichstein P, Gehrke T, Lombardi A, Romano C, Stockley I, Babis G, Bialecki J, Bucsi L, Cai X, Cao L, de Beaubien B, Erhardt J, Goodman S, Jiranek W, Keogh P, Lewallen D, Manner P, Marczynski W, Mason JB, Mulhall K, Paprosky W, Patel P, Piccaluga F, Polkowski G, Suarez J, Thorey F, Tikhilov R, Velazquez JD, Winkler H (2014) One-stage vs two-stage exchange. J Arthroplast 29:108. doi:10.1016/j.arth.2013.09.048

    Article  Google Scholar 

  2. Katz JN, Losina E, Barrett J, Phillips CB (2001) Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg 83:1622–1629

    Article  PubMed  Google Scholar 

  3. Pulido L, Ghanem E, Joshi A, Purtill JJ (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710. doi:10.1007/s11999-008-0209-4

    Article  PubMed  PubMed Central  Google Scholar 

  4. Puhto AP, Puhto T, Syrjala H (2012) Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect 18:1143. doi:10.1111/j.1469-0691.2011.03693.x

    Article  CAS  PubMed  Google Scholar 

  5. Phillips JE, Crane TP, Noy M, Elliott TSJ, Grimer RJ (2006) The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br Vol 88-B:943. doi:10.1302/0301-620x.88b7.17150

    Article  Google Scholar 

  6. Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL (2008) Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 59:1713. doi:10.1002/art.24060

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schmalzried TP (2006) The infected hip: telltale signs and treatment options. J Arthroplast 21:97. doi:10.1016/j.arth.2006.02.090

    Article  Google Scholar 

  8. Anagnostakos K (2009) Classification of hip joint infections. Int J Med Sci 6:227–233. doi:10.7150/ijms.6.227

    Article  PubMed  PubMed Central  Google Scholar 

  9. Berend KR, Lombardi AV, Morris MJ, Bergeson AG, Adams JB, Sneller MA (2012) Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 471:510. doi:10.1007/s11999-012-2595-x

    Article  PubMed Central  Google Scholar 

  10. Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, Mclardy-Smith P, Gundle R, Byren I (2010) Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 65:569. doi:10.1093/jac/dkp469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kilgus DJ, Howe DJ, Strang A (2002) Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 404:116. doi:10.1097/00003086-200211000-00021

    Article  PubMed  Google Scholar 

  12. Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühlemann K (2008) Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 46:1221. doi:10.1086/529436

    Article  PubMed  Google Scholar 

  13. Hanssen AD, Osmon DR (2002) Evaluation of a staging system for infected hip arthroplasty. Clin Orthop Relat Res 403:16. doi:10.1097/00003086-200210000-00004

    Article  PubMed  Google Scholar 

  14. Giulieri SG, Graber P, Ochsner PE, Zimmerli W (2004) Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32:222–228. doi:10.1007/s15010-004-4020-1

    Article  CAS  PubMed  Google Scholar 

  15. Berbari EF, Osmon DR, Duffy MCT, Harmssen RNW, Mandrekar JN, Hanssen AD, Steckelberg JM (2006) Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 42:216. doi:10.1086/498507

    Article  PubMed  Google Scholar 

  16. Marculescu CE, Cantey JR (2008) Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res 466:1397. doi:10.1007/s11999-008-0230-7

    Article  PubMed  PubMed Central  Google Scholar 

  17. Volin SJ, Hinrichs SH, Garvin KL (2004) Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 427:94–100. doi:10.1097/01.blo.0000143559.34143.3d

    Article  PubMed  Google Scholar 

  18. Widmer AF (2001) New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 33:S94. doi:10.1086/321863

    Article  PubMed  Google Scholar 

  19. Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461:48–53. doi:10.1097/blo.0b013e3181123d4e

    PubMed  Google Scholar 

  20. Ghanem E, Antoci V, Pulido L, Joshi A, Hozack W, Parvizi J (2009) The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 13:e444. doi:10.1016/j.ijid.2009.02.017

    Article  CAS  PubMed  Google Scholar 

  21. Hsieh P, Lee MS, Hsu K, Chang Y, Shih H, Ueng SW (2009) Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 49:1036. doi:10.1086/605593

    Article  PubMed  Google Scholar 

  22. Zmistowski B, Fedorka CJ, Sheehan E, Deirmengian G, Austin MS, Parvizi J (2011) Prosthetic joint infection caused by gram-negative organisms. J Arthroplast 26:104. doi:10.1016/j.arth.2011.03.044

    Article  Google Scholar 

  23. Sabry FY, Buller L, Ahmed S, Klika AK, Barsoum WK (2014) Preoperative prediction of failure following two-stage revision for knee prosthetic joint infections. J Arthroplast 29:115. doi:10.1016/j.arth.2013.04.016

    Article  Google Scholar 

  24. Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M (2015) One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips. Int Orthop. doi:10.1007/s00264-015-2833-4

    PubMed  Google Scholar 

  25. Triantafyllopoulos GK, Poultsides LA, Sakellariou VI, Zhang W, Sculco PK, Ma Y, Sculco TP (2015) Irrigation and debridement for periprosthetic infections of the hip and factors determining outcome. Int Orthop 39:1203. doi:10.1007/s00264-015-2753-3

    Article  PubMed  Google Scholar 

  26. Vielgut I, Sadoghi P, Wolf M, Holzer L, Leithner A, Schwantzer G, Poolman R, Frankl B, Glehr M (2015) Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage? Int Orthop 39(9):1731–1736. doi:10.1007/s00264-015-2751-5

    Article  PubMed  Google Scholar 

  27. Wimmer MD, Friedrich MJ, Randau TM, Ploeger MM, Schmolders J, Strauss AA, Hischebeth GTR, Pennekamp PH, Vavken P, Gravius S (2015) Polymicrobial infections reduce the cure rate in prosthetic joint infections: outcome analysis with two-stage exchange and follow-up ≥two years. Int Orthop. doi:10.1007/s00264-015-2871-y

    Google Scholar 

Download references

Acknowledgments

This study was supported by the grant №115030510010 from the Ministry of Health of the Russian Federation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Svetlana Bozhkova.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tikhilov, R., Bozhkova, S., Denisov, A. et al. Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. International Orthopaedics (SICOT) 40, 1381–1387 (2016). https://doi.org/10.1007/s00264-015-3072-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-015-3072-4

Keywords

Navigation